SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-038584
Filing Date
2023-03-30
Accepted
2023-03-30 06:03:29
Documents
13
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2310752d2_8ka.htm   iXBRL 8-K/A 52473
2 EXHIBIT 10.2 tm2310752d2_ex10-2.htm EX-10.2 416379
  Complete submission text file 0001104659-23-038584.txt   735219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20230329.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20230329_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20230329_pre.xml EX-101.PRE 22591
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2310752d2_8ka_htm.xml XML 4992
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37977 | Film No.: 23777019
SIC: 2834 Pharmaceutical Preparations